Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Routine screening for HIV infection--timely and cost-effective.

Bozzette SA.

N Engl J Med. 2005 Feb 10;352(6):620-1. No abstract available.

PMID:
15703428
2.

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK.

N Engl J Med. 2005 Feb 10;352(6):570-85.

3.

Summaries for patients. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

[No authors listed]

Ann Intern Med. 2006 Dec 5;145(11):I30. No abstract available.

PMID:
17146061
4.

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

Paltiel AD, Weinstein MC, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, Freedberg KA, Walensky RP.

N Engl J Med. 2005 Feb 10;352(6):586-95.

5.
6.

Who should be screened for HIV infection? A cost-effectiveness analysis.

McCarthy BD, Wong JB, Muñoz A, Sonnenberg FA.

Arch Intern Med. 1993 May 10;153(9):1107-16.

PMID:
8481077
7.

Cost-effectiveness of screening for HIV.

da Silveira E.

N Engl J Med. 2005 May 19;352(20):2137-9; author reply 2137-9. No abstract available.

PMID:
15906436
8.

The cost effectiveness of voluntary prenatal and routine newborn HIV screening in the United States.

Zaric GS, Bayoumi AM, Brandeau ML, Owens DK.

J Acquir Immune Defic Syndr. 2000 Dec 15;25(5):403-16.

PMID:
11141240
9.

Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.

Kumar M, Birch S, Maturana A, Gafni A.

Health Policy. 2006 Jul;77(2):233-43. Epub 2005 Aug 26.

PMID:
16126300
10.

The cost effectiveness of universal antenatal screening for HIV in New Zealand.

Bramley D, Graves N, Walker D.

AIDS. 2003 Mar 28;17(5):741-8.

PMID:
12646798
11.

Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis.

Hu D, Hook EW 3rd, Goldie SJ.

Ann Intern Med. 2004 Oct 5;141(7):501-13. Erratum in: Ann Intern Med. 2004 Nov 2;141(9):744.

PMID:
15466767
12.

Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.

Pinkerton SD, Holtgrave DR, Pinkerton HJ.

Arch Intern Med. 1997 Sep 22;157(17):1972-80.

PMID:
9308509
13.

Cost-effectiveness of HIV screening in acute care settings.

Owens DK, Nease RF Jr, Harris RA.

Arch Intern Med. 1996 Feb 26;156(4):394-404.

PMID:
8607724
14.

Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.

Rozenbaum MH, Verweel G, Folkerts DK, Dronkers F, van den Hoek JA, Hartwig NG, de Groot R, Postma MJ.

Int J STD AIDS. 2008 Oct;19(10):668-75. doi: 10.1258/ijsa.2008.008077.

PMID:
18824618
15.

Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.

Plunkett BA, Grobman WA.

Am J Obstet Gynecol. 2005 Apr;192(4):1153-61.

PMID:
15846195
16.

Summaries for patients. The cost-effectiveness of screening for Chlamydia in women 15 to 29 years of age.

[No authors listed]

Ann Intern Med. 2004 Oct 5;141(7):I29. No abstract available.

PMID:
15466762
17.

The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.

Bishai D, Colchero A, Durack DT.

AIDS. 2007 Jun 19;21(10):1333-40.

PMID:
17545710
19.

Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.

Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.

Lung Cancer. 2005 May;48(2):171-85. Epub 2005 Jan 4.

PMID:
15829317
20.

The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.

Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA.

Ann Intern Med. 1999 Jan 19;130(2):97-107.

PMID:
10068381

Supplemental Content

Support Center